To understand control interventions, the molecular epidemiology of acute hemorrhagic conjunctivitis (AHC) was investigated from 2004 to 2014.A total of 613,485 AHC cases (annualized cases 55,771) with two deaths were included. Our findings showed that AHC was reported in all provinces, predominantly in Southern and Eastern China. The incidence rates were highest in 2007 (5.65/100,000) and 2010 (21.78/100,000) respectively. A clear seasonal pattern was identified with a peak from August to October. AHC cases occurred in all age groups; however, five to 14 years was the predominant group [23.06%, 133, 510/578,909]. The median age was 24 years (one month~97 years). The median duration from onset to diagnosis was 1.5 days, and there was no difference between the <15, 15~60 and >60-year-old patients [p = 0.0653]. The phylogenetic analysis of 100 nonstructural proteins (3C) and 84 structural proteins (VP1) revealed that AHC outbreaks were caused by Coxsackievirus A24 variant. Genotypes G4-c5a, G4-c5b, and G4-c3 co-circulated with both temporal and geographical overlaps. In conclusion, despite the overall steady decline in the number of AHC cases since the peak in 2010, it still remains a serious public health problem in Southern and Eastern China that targets on the school aged children under 15 years old.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362916PMC
http://dx.doi.org/10.1038/srep45202DOI Listing

Publication Analysis

Top Keywords

ahc cases
12
molecular epidemiology
8
epidemiology acute
8
acute hemorrhagic
8
hemorrhagic conjunctivitis
8
southern eastern
8
eastern china
8
ahc
6
conjunctivitis caused
4
caused coxsackie
4

Similar Publications

Objective: Acute hemorrhagic conjunctivitis (AHC), commonly called pink eye, saw an alarming increase in incidence from July to September 2023 in different parts of India. Pink eye occurrences had reportedly increased three to four times more than in prior years, raising concerns among the community and healthcare professionals. This study aimed to identify the aetiological agent associated with AHC in 2023, genetically characterize the agent and describe the clinical presentation.

View Article and Find Full Text PDF

Purpose: The study aims to investigate an outbreak of acute haemorrhagic conjunctivitis (AHC) reported in North India.

Methods: All patients presenting to the outpatient clinic department with signs and symptoms (symptoms onset within 36 h) of AHC were enrolled in the study. The conjunctival swab samples were tested for the presence of enteroviruses and adenoviruses.

View Article and Find Full Text PDF

Pathogenic variants in ATP1A3 encoding the neuronal Na/K-ATPase cause a spectrum of neurodevelopmental disorders including alternating hemiplegia of childhood (AHC). Three recurrent ATP1A3 variants are associated with approximately half of known AHC cases and mouse models of two of these variants (p.D801N, p.

View Article and Find Full Text PDF

Introduction: Acute hemorrhagic conjunctivitis (AHC) outbreaks are caused mostly by viruses. During July-August 2023, there was a sudden spike in acute hemorrhage conjunctivitis cases in Eastern Uttar Pradesh, India. To identify the etiological and gain molecular epidemiology of the agent, the study was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • Evobrutinib, a BTK inhibitor, was evaluated for safety and efficacy against teriflunomide in treating relapsing multiple sclerosis in two phase 3 trials involving nearly 2,300 participants across 52 countries.
  • Participants aged 18-55 with specific disability scores were randomly assigned to receive either evobrutinib or teriflunomide, with both studies designed as double-blind to avoid bias among participants and researchers.
  • The primary endpoint was the annualized relapse rate over 156 weeks, with data collected from June 2020 to October 2023, showing that 66-67% of the participants were female across the trials.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!